|
C18ORF55 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.69630000046439E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.57670000003429E-06 |
| Normal-vs-Stage2 |
4.979600E-02 |
| Normal-vs-Stage3 |
8.377900E-04 |
| Normal-vs-Stage4 |
4.95270000011594E-07 |
| Stage1-vs-Stage2 |
6.431600E-01 |
| Stage1-vs-Stage3 |
3.820600E-01 |
| Stage1-vs-Stage4 |
5.286000E-02 |
| Stage2-vs-Stage3 |
3.040000E-01 |
| Stage2-vs-Stage4 |
7.893800E-02 |
| Stage3-vs-Stage4 |
5.047600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.01760000001694E-06 |
| Normal-vs-AfricanAmerican |
1.798170E-04 |
| Normal-vs-Asian |
4.77180000002519E-06 |
| Caucasian-vs-AfricanAmerican |
6.345800E-01 |
| Caucasian-vs-Asian |
1.944610E-01 |
| AfricanAmerican-vs-Asian |
2.298400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.9447999977682E-08 |
| Normal-vs-Female |
1.077920E-02 |
| Male-vs-Female |
2.903800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.371200E-04 |
| Normal-vs-Extreme_Weight |
1.76689999997759E-06 |
| Normal-vs-Obese |
1.053570E-02 |
| Normal-vs-Extreme_Obese |
8.412200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.793200E-01 |
| Normal_Weight-vs-Obese |
7.919000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.630000E-01 |
| Extreme_Weight-vs-Obese |
5.963400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.103600E-01 |
| Obese-vs-Extreme_Obese |
3.897200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.60555999999534E-05 |
| Normal-vs-Age(41-60Yrs) |
2.19710000000095E-05 |
| Normal-vs-Age(61-80Yrs) |
2.02119999999084E-05 |
| Normal-vs-Age(81-100Yrs) |
1.133610E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.467000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.891400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.100800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.503600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.852000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.440200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.34139999999439E-06 |
| Normal-VS-Type2 PRCC |
2.361500E-03 |
| Normal-VS-KIRP CIMP |
1.61550000044031E-08 |
| Normal-VS-Unclassified PRCC |
1.826090E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.115000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.080300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.172200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.881800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.841800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.510200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.019300E-04 |
| Normal-vs-N1 |
8.60510000033621E-07 |
| Normal-vs-N2 |
5.98159999976033E-07 |
| N0-vs-N1 |
4.191900E-02 |
| N0-vs-N2 |
3.802100E-02 |
| N1-vs-N2 |
1.980400E-01 |
|
|
